The cost of the medication is an added fee
1 2 3 4 5 6 7 8 "National Drug Code Amphetamine Search Results"
Treatment may be relevant at a BMI of at least 30, or a BMI of 27 in combination with at least one weight-related complication such as high blood pressure, dyslipidemia (elevated blood lipids), or obstructive sleep apnea
Seek immediate medical attention for: Severe, persistent abdominal pain, especially if different from typical IBS pain or radiating to the back (possible pancreatitis) Persistent vomiting preventing adequate fluid intake Signs of dehydration (decreased urination, dizziness, extreme thirst) Severe constipation lasting more than 3-4 days without bowel movement Blood in stool or black, tarry stools Yellowing of skin/eyes, right upper quadrant pain (possible gallbladder disease) Markedly reduced urination (possible acute kidney injury) Fever accompanying gastrointestinal symptoms Neck mass, difficulty swallowing, persistent hoarseness (thyroid concerns) Allergic reactions (rash, itching, swelling, severe dizziness) Scheduled follow-up should occur within 4-6 weeks of initiating therapy and after each dose escalation
Clinical investigator training course
Semaglutide was given FDA approval in June 2021 for weight loss, as trials have yielded encouraging results
